(S)-2-Amino-3-(2,5-difluorophenyl)propanoic acid: Lab Protocol

(S)-2-Amino-3-(2,5-difluorophenyl)propanoic acid is a fluorinated, enantiopure unnatural amino acid widely employed as a building block in peptide synthesis and medicinal chemistry research to modulate metabolic stability, lipophilicity, and receptor-binding selectivity.

Chemical Name

(S)-2-Amino-3-(2,5-difluorophenyl)propanoic acid

Molecular Formula

C9H9F2NO2

Molecular Weight

201.17 g/mol

Stereochemistry

S-configuration (L-form analogue)

Key Functional Groups

Primary amine, carboxylic acid, aromatic ring with 2,5-difluoro substitution

Primary Application

Peptide synthesis building block; pharmacophore in drug discovery

Storage Condition

Store at 2–8 °C, away from moisture and light (verify with CoA)

SKU

A665130

Overview and Chemical Properties

(S)-2-Amino-3-(2,5-difluorophenyl)propanoic acid (Aladdin SKU: A665130) is an enantiopure, non-proteinogenic amino acid that can be viewed as a 2,5-difluorinated analogue of L-phenylalanine. The introduction of fluorine atoms at the 2- and 5-positions of the phenyl ring profoundly alters the electronic and steric environment of the aromatic side chain. Fluorine substitution typically increases the metabolic stability of the aromatic ring toward cytochrome P450-mediated oxidation, modifies pK_a values of adjacent ionizable groups, and can enhance binding affinity to target proteins through orthogonal multipolar interactions (C–F···C=O, C–F···H–N).

The compound is zwitterionic at physiological pH, bearing both an α-amino group (pK_a ~9, typical for α-amino acids) and a carboxylic acid (pK_a ~2). Its S-stereocenter mirrors the configuration of natural L-amino acids, enabling incorporation into peptides with defined stereochemistry.

Materials and Safety Precautions

Required materials:

• (S)-2-Amino-3-(2,5-difluorophenyl)propanoic acid (A665130)
• Analytical balance (±0.01 mg sensitivity)
• Appropriate solvent: water (with dilute HCl or NaOH for full dissolution), DMSO, DMF, or methanol
• Volumetric glassware (glass vials, volumetric flasks)
• Inert atmosphere equipment (nitrogen or argon) if long-term stock solutions are prepared
• pH meter or pH indicator strips

Safety: Although (S)-2-Amino-3-(2,5-difluorophenyl)propanoic acid is not classified as acutely hazardous under standard GHS criteria for this compound class, follow standard laboratory good practices: wear nitrile gloves, safety glasses, and a laboratory coat. Work in a well-ventilated area or fume hood. Consult the Safety Data Sheet (SDS) supplied with the product before use. Avoid inhalation of dust from the solid form. Dispose of waste in accordance with local regulations for fluorinated organic compounds.

Step-by-Step Protocol

1. Stock Solution Preparation

1. Determine the required concentration. A typical stock concentration of 10–100 mM is suitable for most biochemical assays. Calculate the mass required: mass (mg) = concentration (mM) × volume (mL) × molecular weight (g/mol) ÷ 1000.
2. Weigh accurately. Equilibrate the reagent vial to room temperature (15–30 min) before opening to prevent moisture condensation. Tare a clean, dry glass vial and transfer the required amount using a spatula. Record the exact mass.
3. Select solvent. For aqueous solutions, dissolve first in a minimal volume of 0.1 M HCl (protonates the amine, aids dissolution), then adjust pH to the desired value (commonly pH 7.0–7.4 for biological work) with 0.1 M NaOH, and make up to final volume with water or buffer. For organic solvent stocks (DMSO, DMF), the compound dissolves readily; vortex or sonicate briefly if needed. Methanol is an alternative polar protic solvent.
4. Filter if necessary. Pass through a 0.22 µm syringe filter before use in cell-based assays.
5. Aliquot and store. Divide into single-use aliquots in screw-cap microcentrifuge tubes. Flush headspace with inert gas (N₂ or Ar), seal, label with compound name, lot number, concentration, solvent, and date. Store at –20 °C for long-term or 2–8 °C for short-term (up to 2 weeks).

2. Incorporation into Solid-Phase Peptide Synthesis (SPPS)

1. Protection strategy. For Fmoc-SPPS, the free amino acid must first be converted to the Fmoc-protected derivative (Fmoc-Phe(2,5-diF)-OH) or sourced as such. Verify protection status before use. For Boc-SPPS, prepare or source the Boc-protected form accordingly.
2. Coupling. Use standard coupling reagents (e.g., HATU/DIPEA or DIC/Oxyma) in DMF at room temperature. A 3–5-fold excess of the protected amino acid relative to resin loading is recommended. Monitor coupling efficiency by Kaiser test or chloranil test.
3. Deprotection and cleavage. Follow the standard Fmoc deprotection (20% piperidine/DMF) and global deprotection/cleavage protocols appropriate for your side-chain protecting groups. The difluorophenyl ring does not require additional protecting groups.

3. Quality Control

• Confirm identity and purity of stock solutions by analytical HPLC (reverse-phase C18, UV 220 nm) and LC-MS (expect [M+H]⁺ = 202.1 for C₉H₉F₂NO₂).
• Confirm enantiomeric purity by chiral HPLC if stereochemical integrity is critical.
• Cross-reference with the Certificate of Analysis (CoA) provided with each batch.

Troubleshooting

Problem	Likely Cause	Solution
Poor solubility in neutral aqueous buffer	Zwitterion form has low net solubility at isoelectric point	Adjust pH below 2 (full protonation) or above 10 (full deprotonation); alternatively use DMSO co-solvent (≤10% v/v final)
Degradation of stock solution	Oxidation, moisture ingress, or repeated freeze-thaw cycles	Use inert-gas-purged single-use aliquots; store desiccated
Low coupling yield in SPPS	Steric hindrance of ortho-fluorine; slow coupling kinetics	Extend coupling time (60–120 min); use double coupling; switch to more activated reagent (e.g., PyAOP)
Racemization during coupling	Prolonged activation or basic conditions	Use racemization-suppressing additives (Oxyma, HOAt); minimize base concentration; keep coupling at room temperature
Unexpected LC-MS peak	Lactamization or esterification under acidic cleavage conditions	Optimize cleavage cocktail; use fresh TFA; confirm with authentic standard

Applications and Research Context

(S)-2-Amino-3-(2,5-difluorophenyl)propanoic acid finds application across several areas of chemical biology and drug discovery:

• Peptidomimetics and constrained peptides: Fluorinated phenylalanine analogues are incorporated to probe binding pockets in receptor–ligand studies, offering steric and electronic variation without dramatically altering side-chain topology.
• Metabolic stability enhancement: Fluorine substitution at positions susceptible to aromatic hydroxylation (e.g., para-position, here addressed by the 5-fluoro substituent) blocks cytochrome P450-mediated oxidative metabolism, a key strategy in medicinal chemistry lead optimization.
• 19F NMR probes: Compounds bearing aryl fluorines can serve as ¹⁹F NMR reporters in protein-ligand binding studies, exploiting the high sensitivity and wide chemical shift range of fluorine NMR.
• Pharmaceutical intermediate: The compound may serve as a chiral building block for the synthesis of fluorinated drug candidates targeting amino acid transporters, enzymes with phenylalanine-binding sites, or GPCRs modulated by phenylalanine-containing endogenous ligands.

Researchers should validate activity data in their specific biological systems, as fluorine substitution pattern and position significantly influence both potency and selectivity.

Frequently asked questions

What solvents are recommended for dissolving (S)-2-Amino-3-(2,5-difluorophenyl)propanoic acid?

The compound dissolves best in dilute aqueous acid (e.g., 0.1 M HCl), DMSO, or DMF. For aqueous biological work, dissolve in dilute HCl first, then adjust to physiological pH with NaOH. Avoid neutral-pH water alone, as the zwitterionic form has limited solubility at the isoelectric point.

How should (S)-2-Amino-3-(2,5-difluorophenyl)propanoic acid be stored to maintain stability?

Store the solid at 2–8 °C in a tightly sealed container away from light and moisture. For prepared stock solutions, divide into single-use aliquots, purge with inert gas, and store at –20 °C to minimize degradation from repeated freeze-thaw cycles. Always confirm storage recommendations with the Certificate of Analysis provided with each lot.

Can this compound be directly used as a building block in Fmoc solid-phase peptide synthesis?

The free amino acid (A665130) requires Fmoc protection of the alpha-amine before it can be used directly in standard Fmoc-SPPS. Either prepare the Fmoc derivative in-house using standard Fmoc-OSu or Fmoc-Cl protection protocols, or source the pre-protected Fmoc-Phe(2,5-diF)-OH from a specialist supplier. The difluorophenyl ring does not require side-chain protection.

Why is the S-configuration specified, and does chirality matter for typical applications?

The S-configuration corresponds to the L-amino acid arrangement found in natural proteins, making it the biologically and pharmacologically relevant form for most receptor-binding and enzymatic studies. Using the correct enantiomer is critical for stereochemically sensitive assays, peptidomimetic design, and regulatory-compliant pharmaceutical synthesis. Racemic or R-enantiomer material may give substantially different biological results.

How can I confirm the purity and enantiomeric integrity of the received batch?

Review the Certificate of Analysis (CoA) supplied with the product for HPLC purity data and optical rotation. For independent verification, analyze by reverse-phase HPLC (C18, UV 220 nm) for chemical purity and by chiral HPLC for enantiomeric excess (ee). LC-MS confirmation of the molecular ion ([M+H]+ = 202.1) validates identity.

References

1. Fluorine in Medicinal Chemistry and Chemical Biology. Ojima, I. (Ed.). Wiley-Blackwell, 2009. General reference for fluorinated amino acids in drug discovery.
2. Welch, J. T.; Eswarakrishnan, S. Fluorine in Bioorganic Chemistry. Oxford University Press, 1991. Foundational text on electronic and steric effects of aryl fluorine substitution.
3. Muller, K.; Faeh, C.; Diederich, F. Fluorine in pharmaceuticals: looking beyond intuition. Science, 2007, 317(5846), 1881-1886. doi:10.1126/science.1131943
4. Chan, W. C.; White, P. D. (Eds.) Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press, 2000. Standard reference for SPPS protocols.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.